Company profile
Ticker
CMPI
Exchange
Website
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
SEC CIK
Corporate docs
Subsidiaries
Checkmate Pharmaceuticals Security Corporation, Inc. ...
IRS number
364813934
CMPI stock data
Latest filings (excl ownership)
15-12B
Securities registration termination
10 Jun 22
EFFECT
Notice of effectiveness
2 Jun 22
25-NSE
Exchange delisting
31 May 22
S-8 POS
Registration of securities for employees (post-effective amendment)
31 May 22
S-8 POS
Registration of securities for employees (post-effective amendment)
31 May 22
S-8 POS
Registration of securities for employees (post-effective amendment)
31 May 22
POS AM
Prospectus update (post-effective amendment)
31 May 22
8-K
Completion of Acquisition or Disposition of Assets
31 May 22
SC 14D9/A
Tender offer solicitation (amended)
31 May 22
SC TO-T/A
Third party tender offer statement (amended)
31 May 22
Latest ownership filings
SC 13G/A
venBio Global Strategic Fund II L.P.
7 Jun 22
SC 13D/A
GARDNER LEWIS ASSET MANAGEMENT L P
7 Jun 22
SC 13D/A
Novo Holdings A/S
3 Jun 22
SC 13D
GARDNER LEWIS ASSET MANAGEMENT L P
3 Jun 22
4
MICHAEL POWELL
31 May 22
4
Keith T. Flaherty
31 May 22
4
Oren Isacoff
31 May 22
4
Peter Colabuono
31 May 22
4
Joy Yan
31 May 22
4
Robert Dolski
31 May 22
Financial summary
Quarter (USD) | Mar 22 | Dec 21 | Sep 21 | Jun 21 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 21 | Dec 20 | |
---|---|---|---|
Revenue | |||
Cost of revenue | |||
Operating income | |||
Operating margin | |||
Net income | |||
Net profit margin | |||
Cash on hand | |||
Change in cash | |||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | |||
---|---|---|---|---|---|---|
Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q | |
Cash on hand (at last report) | 39.50 mm | 39.50 mm | 39.50 mm | 39.50 mm | 39.50 mm | 39.50 mm |
Cash burn (monthly) | 3.73 mm | (no burn) | 5.30 mm | 5.26 mm | 3.56 mm | 4.17 mm |
Cash used (since last report) | 129.64 mm | n/a | 183.94 mm | 182.87 mm | 123.54 mm | 144.96 mm |
Cash remaining | -90.15 mm | n/a | -144.44 mm | -143.37 mm | -84.04 mm | -105.46 mm |
Runway (months of cash) | -24.2 | n/a | -27.3 | -27.2 | -23.6 | -25.3 |
Institutional ownership, Q1 2022
62.4% owned by funds/institutions
13F holders | Current |
---|---|
Total holders | 24 |
Opened positions | 16 |
Closed positions | 1 |
Increased positions | 1 |
Reduced positions | 4 |
13F shares | Current |
---|---|
Total value | 43.06 mm |
Total shares | 13.50 mm |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
Sofinnova Investments | 3.61 mm | $11.51 mm |
Novo Holdings A/S | 2.16 mm | $6.90 mm |
Medicxi Ventures Management | 1.50 mm | $4.79 mm |
Omega Fund Management | 1.34 mm | $4.26 mm |
Decheng Capital Management III | 1.33 mm | $4.25 mm |
Clough Capital Partners L P | 1.14 mm | $3.63 mm |
FMR | 966.23 k | $3.08 mm |
Vanguard | 556.42 k | $1.78 mm |
Sectoral Asset Management | 541.77 k | $1.73 mm |
Bridgeway Capital Management | 106.50 k | $340.00 k |